WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001002397) TRICYCLIC COMPOUNDS HAVING SPIRO UNION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/002397    International Application No.:    PCT/JP2000/004374
Publication Date: 11.01.2001 International Filing Date: 30.06.2000
Chapter 2 Demand Filed:    22.01.2001    
IPC:
C07D 498/20 (2006.01)
Applicants: MOCHIDA PHARMACEUTICAL CO., LTD. [JP/JP]; 7, Yotsuya 1-chome, Shinjuku-ku, Tokyo 160-8515 (JP) (For All Designated States Except US).
NISHIDA, Hidemitsu [JP/JP]; (JP) (For US Only).
SAITOH, Fumihiko [JP/JP]; (JP) (For US Only).
HARADA, Kousuke [JP/JP]; (JP) (For US Only).
SHIROMIZU, Ikuya [JP/JP]; (JP) (For US Only)
Inventors: NISHIDA, Hidemitsu; (JP).
SAITOH, Fumihiko; (JP).
HARADA, Kousuke; (JP).
SHIROMIZU, Ikuya; (JP)
Agent: WATANABE, Mochitoshi; Hayakawa-tonakai Bldg. 3F, 12-5, Iwamoto-cho 2-chome, Chiyoda-ku, Tokyo 101-0032 (JP)
Priority Data:
11/222883 30.06.1999 JP
Title (EN) TRICYCLIC COMPOUNDS HAVING SPIRO UNION
(FR) COMPOSES TRICYCLIQUES PRESENTANT UNE JONCTION SPIRO
Abstract: front page image
(EN)Aromatic compounds having cyclic amino which are represented by general formula (I) or salts thereof. These compounds are useful as drugs, in particular, activated blood coagulation factor X inhibitors, exert a potent anticoagulation effect and can be orally administered. A pharmacophore derived from the above compounds which is useful in molecular designing Fxa inhibitors.
(FR)L'invention concerne des composés aromatiques comportant un amino cyclique et représentés par la formule générale (I), ou des sels desdits composés. Ces composés sont utiles en tant que médicaments, notamment comme inhibiteurs du facteur X d'activation de la coagulation sanguine. Ils exercent un puissant effet anticoagulant et peuvent être administrés par voie orale. L'invention concerne en outre un pharmacore obtenu à partir desdits composés, qui convient pour la conception moléculaire d'inhibiteurs de Fxa.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)